A day before FDA floated a new competency approach modeled after how physicians are evaluated for regulating generative AI-powered devices, former Obama White House health policy adviser Ezekiel ...
After the postponement of an in-person meeting, the regular work of the United States Preventive Services Task Force (USPSTF) has continued but the postponed meeting has not been rescheduled, coming ...
HHS Secretary Robert F. Kennedy Jr. is doubling down on claims health management organizations (HMOs) are hiding information about vaccines from the federal government, saying at an event on ...
FDA is urging a federal court to dismiss an Administrative Procedure Act (APA) suit filed by an environmental justice (EJ) group and other plaintiffs over its denial of their petition seeking ...
The Trump administration's "most favored nation" agreements for direct-to-consumer drug prices available through TrumpRx are not always the lowest prices available in comparable countries, a new KFF ...
Senate Democrats, with the support of Maine Republican Susan Collins, failed to get the upper chamber to overturn the Trump administration’s 2027 exchange rule, with Sen. Tammy Baldwin (D- WI)’s ...
Louisiana, Arkansas and Alabama are asking the U.S. Supreme Court in a filing Wednesday (Sept. 30) to stop state officials in New York, California and Massachusetts from enforcing their abortion ...
The White House has launched a website that uses Gemini and Grok to deliver information -- and ultimately services -- from across the government, including in the future for Medicare enrollment, with ...
CMS significantly scaled back its controversial “most favored nation” drug-pricing demonstration in Medicare Part B, issuing a final rule Wednesday (Sept. 30) that will save $440 million over seven ...
FDA is launching a dedicated effort to fill vacancies on its advisory committees, the agency said Wednesday (Sept. 30), publishing two Federal Register notices seeking applications from prospective ...
FDA has declined to grant accelerated approval status for Moderna and Merck’s mRNA-4157 melanoma vaccine candidate, currently in a Phase 3 trial, which utilizes artificial intelligence (AI) to ...
Lobbies for employer health plans and pharmacy benefit managers are teaming up to press Congress to pass drug patent reforms, despite their disagreements on key PBM regulations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results